| The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins S Oz, O Kapitansky, Y Ivashco-Pachima, A Malishkevich, E Giladi, ... Molecular psychiatry 19 (10), 1115-1124, 2014 | 116 | 2014 |
| The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities S Oz, Y Ivashko-Pachima, I Gozes PloS one 7 (12), e51458, 2012 | 85 | 2012 |
| Compounds and methods for inhibiting cell death I Gozes, S Oz, JWC Tiong US Patent 10,118,943, 2018 | 4 | 2018 |
| Therapeutics based on tau/microtubule dynamics I Gozes, M Maor, S Oz, D Dangoor, I Divinski US Patent 8,377,875, 2013 | 3 | 2013 |
| SAPIR collision alert system as part of IR MWS suite for helicopter fleets S Nadav, L Varsano, S Oz, R Schlisselberg Infrared Technology and Applications XXXV 7298, 562-572, 2009 | 2 | 2009 |
| The cytoskeleton as a pharmacological target in neurodegenerative diseases S Oz, I Gozes The Cytoskeleton: Imaging, Isolation, and Interaction, 151-169, 2013 | 1 | 2013 |
| P3‐428: Activity‐dependent neuroprotective protein (ADNP) is regulated in the brains of mouse models of human tauopathies: Toward davunetide replacement therapy I Gozes, Y Schirer, S Oz Alzheimer's & Dementia 6, S578-S579, 2010 | 1 | 2010 |
| Method for identifying a modulator of cell survival or plasticity I Gozes, S Oz, JWC Tiong US Patent 10,822,375, 2020 | | 2020 |
| PACAP is an endogenous protective factor-lessons from PACAP deficient mice S Oz, Y Ivashko, I Gozes JOURNAL OF MOLECULAR NEUROSCIENCE 48, S142-S143, 2012 | | 2012 |
| The ADNP derived peptide, NAP, modulates microtubule dynamics: implications for neurotrophic and neuroprotective activities S Oz, Y Ivashko, I Gozes JOURNAL OF MOLECULAR NEUROSCIENCE 48, S44-S45, 2012 | | 2012 |
| Davunetide (NAP) Influences Growth Cone Microtubules and Protects Microtubule-Dependent Axonal Transport I Gozes, S Oz, Y Jouroukhin DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 33, 272-272, 2012 | | 2012 |
| Davunetide (NAP intranasal formulation AL-108) provides cognitive protection in a model of microtubules dysfunction exhibiting schizophrenia-like symptoms I Gozes, A Merenlender-Wagner, S Oz, A Andrieux JOURNAL OF MOLECULAR NEUROSCIENCE 42 (3), 292-293, 2010 | | 2010 |
| Signaling of neuroprotective peptides through the microtubule/tubulin tyrosination cycle S Oz, I Gozes JOURNAL OF MOLECULAR NEUROSCIENCE 42 (3), 305-306, 2010 | | 2010 |
| P4‐075: Davunetide: Targeting Microtubule Dynamics in Dementia Clinical Trials I Gozes, S Oz Alzheimer's & Dementia 6, e44-e44, 2010 | | 2010 |
